Glancy Prongay & Murray LLP Commences Investigation on Behalf of InfuSystem Holdings, Inc. Investors

LOS ANGELES--()--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of InfuSystem Holdings, Inc. (“InfuSystem” or the “Company”) (NYSE: INFU) investors concerning the Company and its officers potential violation of federal securities laws.

On November 1, 2016, the Audit Committee of the Board of Directors of InfuSystem confirmed that the Company’s audited financial statements for the fiscal year ended December 31, 2015, and the Company’s unaudited financial statements for each of the fiscal quarters ended March 31, 2015 through June 30, 2016 should no longer be relied upon. According to InfuSystem, the financial statements are no longer reliable due to an overestimation of accounts receivable collections that ultimately led to inflated revenues.

On this news, shares of InfuSystem have fallen 25% to just $1.95 per share during intra-day trading on November 7, 2016.

If you purchased InfuSystem securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Release Summary

Glancy Prongay & Murray LLP Commences Investigation on Behalf of InfuSystem Holdings, Inc. Investors

Contacts

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com